Breaking News Instant updates and real-time market news.

WEBR

Weber

$5.03 /

-0.225 (-4.29%)

07:29
10/25/22
10/25
07:29
10/25/22
07:29

Weber upgraded to Equal Weight from Underweight at Wells Fargo

Wells Fargo analyst Chris Carey upgraded Weber to Equal Weight from Underweight with a price target of $6.25, up from $4 and equal to the proposed bid price from BDT for the unowned Class A stock. This represents 24.7-times the analyst's 2023 EBITDA, roughly double the peer group average, and entirely reflecting the proposed transaction price at which he expects Weber to trade. In Carey's view, the BDT offer is a 'take it or leave it' type offer and counterbids among other alternatives seem a low probability.

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Boliden downgraded to Sector Perform from Outperform at RBC Capital » 05:12
12/01/22
12/01
05:12
12/01/22
05:12
BDNNY

Boliden

$75.02 /

+2.815 (+3.90%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDNNY Boliden
$75.02 /

+2.815 (+3.90%)

BDNNY Boliden
$75.02 /

+2.815 (+3.90%)

11/18/22 Deutsche Bank
Boliden price target raised to SEK 350 from SEK 330 at Deutsche Bank
10/26/22 Morgan Stanley
Boliden price target lowered to SEK 325 from SEK 375 at Morgan Stanley
10/24/22 Berenberg
Boliden price target lowered to SEK 320 from SEK 340 at Berenberg
10/21/22 JPMorgan
Boliden price target lowered to SEK 305 from SEK 330 at JPMorgan
Downgrade
Anglo American downgraded to Sector Perform from Outperform at RBC Capital » 05:12
12/01/22
12/01
05:12
12/01/22
05:12
NGLOY

Anglo American

$20.50 /

+0.74 (+3.74%)

RBC Capital analyst Tyler…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGLOY Anglo American
$20.50 /

+0.74 (+3.74%)

NGLOY Anglo American
$20.50 /

+0.74 (+3.74%)

11/23/22 Deutsche Bank
Anglo American price target raised to 3,500 GBp from 3,400 GBp at Deutsche Bank
11/02/22 Morgan Stanley
Anglo American price target lowered to 3,160 GBp at Morgan Stanley
10/28/22 JPMorgan
Anglo American price target raised to 4,100 GBp from 4,000 GBp at JPMorgan
10/28/22 Credit Suisse
Anglo American price target lowered to 3,400 GBp at Credit Suisse
NGLOY Anglo American
$20.50 /

+0.74 (+3.74%)

Upgrade
SGS SA upgraded to Buy from Neutral at Citi » 05:09
12/01/22
12/01
05:09
12/01/22
05:09
SGSOY

SGS SA

$23.61 /

+0.74 (+3.24%)

Citi analyst Arthur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGSOY SGS SA
$23.61 /

+0.74 (+3.24%)

SGSOY SGS SA
$23.61 /

+0.74 (+3.24%)

11/25/22 Barclays
SGS SA downgraded to Underweight from Overweight at Barclays
11/21/22 JPMorgan
SGS SA downgraded to Underweight from Neutral at JPMorgan
11/17/22 Morgan Stanley
SGS SA price target lowered to CHF 2,220 from CHF 2,290 at Morgan Stanley
09/27/22 RBC Capital
SGS SA downgraded to Sector Perform from Outperform at RBC Capital
Hot Stocks
Xpeng delivers 5.811 Smart EVs in November » 05:08
12/01/22
12/01
05:08
12/01/22
05:08
XPEV

XPeng

$10.83 /

+3.48 (+47.35%)

XPeng announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
11/28/22 Jefferies
XPeng downgraded to Underperform from Hold at Jefferies
11/22/22 DBS Bank
XPeng initiated with a Buy at DBS Bank (earlier)
11/17/22 UBS
XPeng upgraded to Buy from Neutral at UBS
XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

XPEV XPeng
$10.83 /

+3.48 (+47.35%)

Upgrade
Cellnex Telecom upgraded to Buy from Neutral at UBS » 05:07
12/01/22
12/01
05:07
12/01/22
05:07
CLLNY

Cellnex Telecom

$17.25 /

+0.44 (+2.62%)

UBS analyst Ondrej…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLLNY Cellnex Telecom
$17.25 /

+0.44 (+2.62%)

10/26/22 Jefferies
Cellnex Telecom price target lowered to EUR 40 from EUR 58 at Jefferies
10/17/22 JPMorgan
Cellnex Telecom price target lowered to EUR 54 from EUR 58 at JPMorgan
09/26/22 Barclays
Cellnex Telecom price target lowered to EUR 41 from EUR 66 at Barclays
08/22/22 JPMorgan
Cellnex Telecom price target lowered to EUR 58 from EUR 59 at JPMorgan
CLLNY Cellnex Telecom
$17.25 /

+0.44 (+2.62%)

Downgrade
Wartsila downgraded to Sector Perform from Outperform at RBC Capital » 05:05
12/01/22
12/01
05:05
12/01/22
05:05
WRTBY

Wartsila

$1.64 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WRTBY Wartsila
$1.64 /

+ (+0.00%)

10/05/22 JPMorgan
Wartsila price target lowered to EUR 8.70 from EUR 9.20 at JPMorgan
10/03/22 Morgan Stanley
Wartsila assumed with an Equal Weight at Morgan Stanley
07/22/22 Citi
Wartsila price target raised to EUR 8.50 at Citi
04/29/22 UBS
Wartsila price target lowered to EUR 13.50 from EUR 15 at UBS
Initiation
International Distributions Services initiated with an Outperform at Exane » 05:03
12/01/22
12/01
05:03
12/01/22
05:03
ROYMY

International Distributions Services

$5.59 /

+0.0215 (+0.39%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROYMY International Distributions Services
$5.59 /

+0.0215 (+0.39%)

11/22/22 JPMorgan
International Distributions Services price target raised to 240 GBp from 190 GBp at JPMorgan
10/17/22 Barclays
International Distributions Services downgraded to Equal Weight at Barclays
09/30/22 Deutsche Bank
Royal Mail price target lowered to 144 GBp from 222 GBp at Deutsche Bank
09/16/22 JPMorgan
Royal Mail downgraded to Neutral from Overweight at JPMorgan
Upgrade
L'Oreal upgraded to Neutral from Sell at Citi » 05:01
12/01/22
12/01
05:01
12/01/22
05:01
LRLCY

L'Oreal

$74.41 /

+2.458 (+3.42%)

Citi analyst Cedric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

04:56 Today JPMorgan
L'Oreal downgraded to Neutral from Overweight at JPMorgan
10/25/22 Berenberg
L'Oreal price target lowered to EUR 314 from EUR 347 at Berenberg
10/24/22 Barclays
L'Oreal price target lowered to EUR 375 from EUR 416 at Barclays
10/11/22 Morgan Stanley
L'Oreal price target lowered to EUR 365 from EUR 385 at Morgan Stanley
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

Upgrade
Essity upgraded to Neutral from Underweight at JPMorgan » 04:59
12/01/22
12/01
04:59
12/01/22
04:59
ETTYF

Essity

$22.85 /

-1.017 (-4.26%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETTYF Essity
$22.85 /

-1.017 (-4.26%)

11/22/22 Exane BNP Paribas
Essity upgraded to Outperform from Neutral at Exane BNP Paribas
11/01/22 Berenberg
Essity price target lowered to SEK 254 from SEK 266 at Berenberg
10/28/22 JPMorgan
Essity price target raised to SEK 220 from SEK 210 at JPMorgan
10/28/22 Credit Suisse
Essity price target lowered to SEK 286 from SEK 308 at Credit Suisse
Downgrade
Givaudan downgraded to Underweight from Neutral at JPMorgan » 04:59
12/01/22
12/01
04:59
12/01/22
04:59
GVDNY

Givaudan

$67.37 /

+1.7 (+2.59%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GVDNY Givaudan
$67.37 /

+1.7 (+2.59%)

GVDNY Givaudan
$67.37 /

+1.7 (+2.59%)

10/13/22 Berenberg
Givaudan price target lowered to CHF 3,600 from CHF 3,800 at Berenberg
10/12/22 JPMorgan
Givaudan price target lowered to CHF 2,700 from CHF 3,300 at JPMorgan
10/12/22 Credit Suisse
Givaudan price target lowered to CHF 2,400 from CHF 2,900 at Credit Suisse
09/29/22 Citi
Givaudan upgraded to Buy from Neutral at Citi
Downgrade
Remy Cointreau downgraded to Underweight from Neutral at JPMorgan » 04:58
12/01/22
12/01
04:58
12/01/22
04:58
REMYY

Remy Cointreau

$17.26 /

+0.56 (+3.35%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$17.26 /

+0.56 (+3.35%)

10/26/22 Credit Suisse
Remy Cointreau price target lowered to EUR 155 from EUR 190 at Credit Suisse
10/26/22 Barclays
Remy Cointreau price target lowered to EUR 257 from EUR 325 at Barclays
10/12/22 Morgan Stanley
Remy Cointreau price target lowered to EUR 155 from EUR 160 at Morgan Stanley
09/12/22 Deutsche Bank
Remy Cointreau price target raised to EUR 310 from EUR 304 at Deutsche Bank
Downgrade
Davide Campari-Milano downgraded to Neutral from Overweight at JPMorgan » 04:57
12/01/22
12/01
04:57
12/01/22
04:57
DVDCF

Davide Campari-Milano

$10.90 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DVDCF Davide Campari-Milano
$10.90 /

+ (+0.00%)

11/08/22 Morgan Stanley
Davide Campari-Milano price target lowered to EUR 9.30 at Morgan Stanley
11/02/22 Societe Generale
Davide Campari-Milano price target lowered to EUR 12 at Societe Generale
11/01/22 Credit Suisse
Davide Campari-Milano price target lowered to EUR 10 from EUR 11.90 at Credit Suisse
11/01/22 Deutsche Bank
Davide Campari-Milano upgraded to Buy from Hold at Deutsche Bank
Downgrade
L'Oreal downgraded to Neutral from Overweight at JPMorgan » 04:56
12/01/22
12/01
04:56
12/01/22
04:56
LRLCY

L'Oreal

$74.41 /

+2.458 (+3.42%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

10/25/22 Berenberg
L'Oreal price target lowered to EUR 314 from EUR 347 at Berenberg
10/24/22 Barclays
L'Oreal price target lowered to EUR 375 from EUR 416 at Barclays
10/11/22 Morgan Stanley
L'Oreal price target lowered to EUR 365 from EUR 385 at Morgan Stanley
10/11/22 Deutsche Bank
L'Oreal price target lowered to EUR 380 from EUR 400 at Deutsche Bank
LRLCY L'Oreal
$74.41 /

+2.458 (+3.42%)

Conference/Events
Senate Agriculture, Nutrition & Forrestry Committee to hold a hearing » 04:55
12/01/22
12/01
04:55
12/01/22
04:55

The Committee holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS semiconductor analyst to hold an analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
ADI

Analog Devices

$171.83 /

+7.89 (+4.81%)

Semiconductors Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

11/23/22 Deutsche Bank
Analog Devices price target raised to $170 from $155 at Deutsche Bank
11/23/22 Evercore ISI
Analog Devices price target raised to $195 from $185 at Evercore ISI
11/23/22 Truist
Analog Devices price target raised to $214 from $209 at Truist
11/23/22 Cowen
Analog Devices price target raised to $190 from $180 at Cowen
ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

ADI Analog Devices
$171.83 /

+7.89 (+4.81%)

Conference/Events
Intellia Therapeutics to participate in a conference call with JPMorgan » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
NTLA

Intellia Therapeutics

$51.41 /

+3.44 (+7.17%)

SMid Cap Biotech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

11/14/22 Chardan
Intellia Therapeutics price target raised to $129 from $121 at Chardan
11/03/22 Chardan
Intellia Therapeutics price target lowered to $121 from $146 at Chardan
10/31/22 EF Hutton
Intellia Therapeutics initiated with a Buy at EF Hutton
10/11/22 Morgan Stanley
Intellia Therapeutics initiated with an Overweight at Morgan Stanley
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

  • 01
    Dec
NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

NTLA Intellia Therapeutics
$51.41 /

+3.44 (+7.17%)

Conference/Events
Standard Motor management to meet virtually with MKM Partners » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SMP

Standard Motor

$38.37 /

+0.6 (+1.59%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

10/18/22 MKM Partners
Standard Motor price target lowered to $47 from $57 at MKM Partners
06/09/22 MKM Partners
Standard Motor initiated with a Buy at MKM Partners
SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

SMP Standard Motor
$38.37 /

+0.6 (+1.59%)

Conference/Events
Humana to participate in a conference call with Mizuho » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
HUM

Humana

$550.14 /

+16.53 (+3.10%)

Conference call to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

11/08/22 Wells Fargo
Humana price target raised to $610 from $558 at Wells Fargo
11/07/22 Cowen
Humana price target raised to $647 from $547 at Cowen
11/03/22 Truist
Humana price target raised to $650 from $570 at Truist
11/03/22 RBC Capital
Humana price target raised to $637 from $560 at RBC Capital
HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

HUM Humana
$550.14 /

+16.53 (+3.10%)

Hot Stocks
Sabre to replace Flagstar Bancorp in the S&P 600 at open on 12/1 » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SABR

Sabre

$6.10 /

+0.325 (+5.63%)

, FBC

Flagstar Bancorp

$37.55 /

+0.45 (+1.21%)

Nexstar Media Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SABR Sabre
$6.10 /

+0.325 (+5.63%)

FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

10/17/22 Mizuho
Sabre price target lowered to $6 from $7 at Mizuho
09/28/22 Redburn
Sabre initiated with a Buy at Redburn
09/08/22 Mizuho
Sabre price target lowered to $7 from $8 at Mizuho
08/22/22 Mizuho
Sabre price target raised to $8 from $7 at Mizuho
FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

07/11/22 B. Riley
Flagstar Bancorp price target lowered to $40 from $44 at B. Riley
06/14/22 B. Riley
Flagstar Bancorp downgraded to Neutral from Buy at B. Riley
06/14/22 B. Riley
Flagstar Bancorp downgraded to Neutral from Buy at B. Riley
06/02/22 Keefe Bruyette
New York Community downgraded to Market Perform at Keefe Bruyette
SABR Sabre
$6.10 /

+0.325 (+5.63%)

FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

FBC Flagstar Bancorp
$37.55 /

+0.45 (+1.21%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

SABR Sabre
$6.10 /

+0.325 (+5.63%)

Conference/Events
CCC Intelligent Solutions management to meet with Piper Sandler » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
CCCS

CCC Intelligent Solutions

$9.18 /

+0.31 (+3.50%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCCS CCC Intelligent Solutions
$9.18 /

+0.31 (+3.50%)

11/01/22 Citi
CCC Intelligent Solutions price target lowered to $10 from $11 at Citi
10/21/22 Barclays
CCC Intelligent Solutions initiated with an Equal Weight at Barclays
08/08/22 Piper Sandler
CCC Intelligent Solutions initiated with a Neutral at Piper Sandler
07/13/22 Goldman Sachs
CCC Intelligent Solutions upgraded to Buy from Neutral at Goldman Sachs
CCCS CCC Intelligent Solutions
$9.18 /

+0.31 (+3.50%)

  • 07
    Apr
Conference/Events
S&P Global to host investor day » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
SPGI

S&P Global

$352.79 /

+6.24 (+1.80%)

Investor Day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

11/28/22 BMO Capital
S&P Global price target raised to $393 from $355 at BMO Capital
11/07/22 Atlantic Equities
Atlantic upgrades S&P Global to Overweight on 'high-quality' business
11/07/22 Atlantic Equities
S&P Global upgraded to Overweight from Neutral at Atlantic Equities
11/01/22 Argus
S&P Global price target lowered to $365 from $420 at Argus
SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

SPGI S&P Global
$352.79 /

+6.24 (+1.80%)

Conference/Events
Needham healthcare analyst to hold an analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
ALC

Alcon

$68.89 /

+1.585 (+2.36%)

, BLCO

Bausch + Lomb

$15.13 /

+0.61 (+4.20%)

, COO

Cooper Companies

$316.13 /

+8.85 (+2.88%)

, GKOS

Glaukos

$46.51 /

+0.84 (+1.84%)

, JNJ

Johnson & Johnson

$177.94 /

+1.895 (+1.08%)

, RXST

RxSight

$12.75 /

+0.64 (+5.28%)

, SGHT

Sight Sciences

$11.08 /

+0.53 (+5.02%)

, STAA

Staar Surgical

$57.04 /

+1.61 (+2.90%)

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALC Alcon
$68.89 /

+1.585 (+2.36%)

BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

SGHT Sight Sciences
$11.08 /

+0.53 (+5.02%)

STAA Staar Surgical
$57.04 /

+1.61 (+2.90%)

ALC Alcon
$68.89 /

+1.585 (+2.36%)

11/21/22 Credit Suisse
Alcon price target lowered to CHF 80 from CHF 84 at Credit Suisse
11/17/22 Societe Generale
Societe Generale downgrades Alcon to Sell with Q3 'last good quarter'
11/17/22 Societe Generale
Alcon downgraded to Sell from Hold at Societe Generale
11/17/22 Wells Fargo
Alcon price target lowered to $83 from $90 at Wells Fargo
BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

11/03/22 H.C. Wainwright
Bausch + Lomb price target lowered to $20 from $21 at H.C. Wainwright
09/12/22 H.C. Wainwright
Bausch + Lomb initiated with a Buy at H.C. Wainwright
07/28/22 RBC Capital
RBC says court ruling on Xifaxan looks like 'worst possible outcome' for Bausch
07/28/22 JPMorgan
JPMorgan downgrades Bausch on 'near-worst-case scenario' ruling
COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

11/30/22 Baird
Cooper Companies upgraded to Outperform from Neutral at Baird
11/28/22 JPMorgan
Cooper Companies price target raised to $330 from $300 at JPMorgan
11/03/22 Piper Sandler
Cooper Companies price target lowered to $355 from $375 at Piper Sandler
10/11/22 Jefferies
Cooper Companies downgraded to Hold from Buy at Jefferies
GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

11/03/22 Piper Sandler
Glaukos price target raised to $60 from $55 at Piper Sandler
10/13/22 Stephens
Glaukos resumed with an Overweight at Stephens
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/05/22 Citi
Glaukos price target raised to $57 from $54 at Citi
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
11/28/22 Morgan Stanley
Genmab risk/reward favorable into arbitration ruling, says Morgan Stanley
11/17/22 Credit Suisse
Johnson & Johnson initiated with a Neutral at Credit Suisse
RXST RxSight
$12.75 /

+0.64 (+5.28%)

10/11/22 BofA
RxSight reinstated with a Buy at BofA
04/19/22 BTIG
J&J results will be viewed favorably for MedTech group, says BTIG
04/08/22 Needham
RxSight initiated with a Buy at Needham
SGHT Sight Sciences
$11.08 /

+0.53 (+5.02%)

10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/11/22 BofA
Sight Sciences reinstated with a Neutral at BofA
10/05/22 Citi
Sight Sciences price target lowered to $9 from $13 at Citi
10/04/22 Needham
Sight Sciences initiated with a Hold at Needham
STAA Staar Surgical
$57.04 /

+1.61 (+2.90%)

11/30/22 Canaccord
Staar Surgical price target lowered to $79 from $88 at Canaccord
11/07/22 Sidoti
Staar Surgical upgraded to Buy from Neutral at Sidoti
11/03/22 Needham
Staar Surgical price target lowered to $83 from $110 at Needham
11/03/22 BTIG
Staar Surgical price target lowered to $80 from $103 at BTIG
ALC Alcon
$68.89 /

+1.585 (+2.36%)

BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

RXST RxSight
$12.75 /

+0.64 (+5.28%)

SGHT Sight Sciences
$11.08 /

+0.53 (+5.02%)

STAA Staar Surgical
$57.04 /

+1.61 (+2.90%)

  • 06
    May
JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

ALC Alcon
$68.89 /

+1.585 (+2.36%)

BLCO Bausch + Lomb
$15.13 /

+0.61 (+4.20%)

COO Cooper Companies
$316.13 /

+8.85 (+2.88%)

GKOS Glaukos
$46.51 /

+0.84 (+1.84%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

JNJ Johnson & Johnson
$177.94 /

+1.895 (+1.08%)

RXST RxSight
$12.75 /

+0.64 (+5.28%)

Conference/Events
BTIG medical technology analyst to hold analyst/industry conference call » 04:55
12/01/22
12/01
04:55
12/01/22
04:55

Medical Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
C.H. Robinson management to meet with Stephens » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
CHRW

C.H. Robinson

$99.61 /

+2.615 (+2.70%)

Meetings to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

11/30/22 Exane BNP Paribas
C.H. Robinson initiated with an Outperform at Exane BNP Paribas
11/30/22 BofA
RXO Inc. initiated with a Buy at BofA
11/15/22 Raymond James
C.H. Robinson downgraded to Underperform from Market Perform at Raymond James
11/15/22 Raymond James
C.H. Robinson downgraded to Underperform from Market Perform at Raymond James
CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

CHRW C.H. Robinson
$99.61 /

+2.615 (+2.70%)

Conference/Events
TPG RE Finance management to meet with BTIG » 04:55
12/01/22
12/01
04:55
12/01/22
04:55
TRTX

TPG RE Finance

$7.42 /

+0.315 (+4.43%)

Mortgage and Specialty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRTX TPG RE Finance
$7.42 /

+0.315 (+4.43%)

11/21/22 BofA
TPG RE Finance reinstated with a Neutral at BofA
11/02/22 BTIG
TPG RE Finance downgraded to Neutral from Buy at BTIG
10/24/22 JPMorgan
TPG RE Finance price target lowered to $9 from $9.50 at JPMorgan
05/06/22 Citi
TPG RE Finance price target lowered to $12 from $14 at Citi
TRTX TPG RE Finance
$7.42 /

+0.315 (+4.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.